Kapadia Sandip
Passage Bio, Inc. · Director
Kapadia Sandip is listed in filings as Director at Passage Bio, Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including sale activity. Recent filings connect the profile to Passage Bio, Inc. (PASG) and Harmony Biosciences Holdings, Inc. (HRMY). The current snapshot covers public activity from Oct 2, 2024 to May 21, 2026. Reported amounts are shown as $53.5K to $94.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $753k21k shares | SellJan 15, 2026 | $35.92 | $33.53 | |
| $791k20k shares | SellDec 5, 2025 | $39.54 | $33.53 | |
| $120k3.4k shares | SellNov 21, 2025 | $35.00 | $33.53 | |
| $787k21.6k shares | SellAug 15, 2025 | $36.50 | $33.53 | |
| $203k6.2k shares | SellApr 1, 2025 | $32.48 | $33.53 | |
| $25k740 shares | SellApr 1, 2025 | $33.12 | $33.53 | |
| $68k1.8k shares | SellJan 27, 2025 | $38.05 | $33.53 | |
| $1M25k shares | SellJan 21, 2025 | $40.18 | $33.53 |